Effects of nicotine vary across two auditory evoked potentials in the mouse
- PMID: 16497274
- DOI: 10.1016/j.biopsych.2005.12.011
Effects of nicotine vary across two auditory evoked potentials in the mouse
Abstract
Background: Schizophrenia patients display sensory processing deficits, reduced alpha7-nicotine receptor expression, and increased incidence of smoking, prompting investigation of nicotine receptor agonists as possible treatments. We evaluated the effects of acute and chronic nicotine, using an animal model that incorporates genetic variation for sensory processing and nicotine sensitivity.
Methods: C57BL/6J and DBA/2Hsd mice received 2 weeks of 4.2 mg/kg chronic nicotine or saline. Auditory evoked potentials were recorded before and after acute nicotine injection of 1.05 mg/kg on day 14, with a paired-click paradigm (S1/S2). Amplitude and gating of the P20 and N40 were compared between conditions.
Results: Acute nicotine increased the amplitude and gating of the P20 and decreased the amplitude and gating of the N40 across all groups, primarily by acting on S1. Chronic nicotine attenuated the effects of acute nicotine on the N40.
Conclusions: Our data support the notion that the mouse P20 shares pharmacological response properties with the human P50. In addition, findings suggest that nicotine might increase the initial sensory response (S1), with a resulting improvement in gating of some components.
Similar articles
-
Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.Neuroscience. 2005;133(3):729-38. doi: 10.1016/j.neuroscience.2005.03.027. Neuroscience. 2005. PMID: 15908134
-
Male and female mice differ for baseline and nicotine-induced event related potentials.Behav Neurosci. 2008 Oct;122(5):982-90. doi: 10.1037/a0012995. Behav Neurosci. 2008. PMID: 18823155
-
Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism.Neuroscience. 2010 Mar 10;166(1):145-56. doi: 10.1016/j.neuroscience.2009.11.053. Epub 2009 Dec 2. Neuroscience. 2010. PMID: 19961902 Clinical Trial.
-
Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism.Psychopharmacology (Berl). 2003 Feb;165(4):386-96. doi: 10.1007/s00213-002-1285-x. Epub 2002 Nov 30. Psychopharmacology (Berl). 2003. PMID: 12459928
-
Translational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation.Transl Psychiatry. 2015 Jun 23;5(6):e587. doi: 10.1038/tp.2015.77. Transl Psychiatry. 2015. PMID: 26101850 Free PMC article. Review.
Cited by
-
Electroencephalographic and early communicative abnormalities in Brattleboro rats.Physiol Rep. 2013 Oct;1(5):e00100. doi: 10.1002/phy2.100. Epub 2013 Oct 20. Physiol Rep. 2013. PMID: 24303172 Free PMC article.
-
Animal Models of Psychosis: Current State and Future Directions.Curr Behav Neurosci Rep. 2014 Jun 1;1(2):100-116. doi: 10.1007/s40473-014-0013-2. Curr Behav Neurosci Rep. 2014. PMID: 25215267 Free PMC article.
-
NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia.Neurobiol Dis. 2012 Apr;46(1):93-100. doi: 10.1016/j.nbd.2011.12.049. Epub 2012 Jan 9. Neurobiol Dis. 2012. PMID: 22245663 Free PMC article.
-
Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials.Neurobiol Dis. 2009 Aug;35(2):311-7. doi: 10.1016/j.nbd.2009.05.012. Epub 2009 May 23. Neurobiol Dis. 2009. PMID: 19467327 Free PMC article.
-
A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice.Neuroscience. 2008 Nov 11;157(1):95-104. doi: 10.1016/j.neuroscience.2008.08.060. Epub 2008 Sep 9. Neuroscience. 2008. PMID: 18835334 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials